Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000214930 | SCV000270830 | likely benign | not specified | 2016-02-09 | criteria provided, single submitter | clinical testing | p.Ile1688Ile in exon 28 of SCN5A: This variant is not expected to have clinical significance because it does not alter an amino acid residue and is not located within the splice consensus sequence. It has been identified in 4/66740 European chromosomes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitu te.org; dbSNP rs145731678). |
Gene |
RCV000214930 | SCV000516829 | benign | not specified | 2015-05-06 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Labcorp Genetics |
RCV002057145 | SCV001009009 | likely benign | not provided | 2023-09-11 | criteria provided, single submitter | clinical testing | |
Color Diagnostics, |
RCV001842979 | SCV001348914 | likely benign | Cardiac arrhythmia | 2018-11-30 | criteria provided, single submitter | clinical testing | |
Ce |
RCV002057145 | SCV002496798 | likely benign | not provided | 2022-02-01 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002338670 | SCV002642760 | likely benign | Cardiovascular phenotype | 2020-09-01 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |